Archives — Current Month (33)

The Perfect Gold Stock for Revivalists (12/15/2017)

Technical analyst Clive Maund charts a young gold company that he believes "is going places."

more>

Cannabis Biotech Stock Starting to Advance Again (12/15/2017)

A technical analysis by Clive Maund on CliveMaund.com has a Buy on this cannabis biotech stock.

more>

New Uranium Assays Improve 'Resource Confidence' (12/14/2017)

David Talbot, an analyst with Eight Capital, outlined recent drill results from this energy company's flagship asset.

more>

Precious Metals Explorer to Acquire 'District-Scale Gold Properties' (12/14/2017)

Craig Stanley, an analyst with Eight Capital, took a look at the terms and potential of this mining company's prospective transactions in Ontario.

more>

Metallic Minerals Catches the Silver Ring (12/14/2017)

Silver is cheap right now, says Bob Moriarty of 321 Gold, who profiles a company in the Yukon that he says is delivering world-class exploration results.

more>

Micro-Cap Oil & Gas Explorer's First Permian Basin Well Flowing 465 Barrels/Day (12/13/2017)

Exploration is just beginning for this oil and gas E&P with large tracts of prime land in the Permian Basin in Texas.

more>

'The Market Gets it Wrong, Again'; Analyst Raises Target Price on Biotech (12/13/2017)

Ed Arce, an analyst with H.C. Wainwright & Co., explained the positive elements of this drug developer's recently released clinical trial data and why they did not warrant the market reaction they got.

more>

Bitcoin Total Wipeout Alert (12/13/2017)

Technical analyst Clive Maund discusses why he thinks Bitcoin is about to take a dive.

more>

Guyana Shield Is Host to Multiple Gold Deposits (12/12/2017)

As two Guyana projects begin commercial gold production, a new mineral resource estimate is in the works for a third project.

more>

Junior Miner Looking Good for Commercial Production in 2018, Analysts Say (12/12/2017)

A flagship Nevada project is showing results and the company anticipates commencing commercial production in the first quarter of 2018.

more>

Gold Major to Increase Dividend by 50% in 2018 (12/11/2017)

BMO Capital Markets reported on this miner's outlook for 2018 and beyond.

more>

Jack Chan's Weekly Precious Metals Market Update (12/11/2017)

Technical analyst Jack Chan charts the latest movements in the gold and silver markets.

more>

Cryptojunkies: Beware the Ides of December (12/11/2017)

As Bitcoin futures are set to begin trading next week, precious metals expert Michael Ballanger discusses movements in gold and cryptocurrencies.

more>

Keith Barron Wants to Mine U3O8 'Cheep' (12/11/2017)

More mining companies should follow the example of the garimpeiro miners of Brazil who mine until they fail to make a profit, says Bob Moriarty of 321 Gold, who discusses one gold and one uranium company that may be changing the paradigm.

more>

Positive Drill Results Confirm Large-Scale Potential for Nevada Lithium Project (12/10/2017)

Drill results from a Nevada lithium project caught the attention of The Critical Investor.

more>

Zinc Explorer Finally Hits at Zone 3; How Big Can the Resource Get? (12/09/2017)

The Critical Investor provides an update on this zinc explorer's latest drill results.

more>

A New Breed of Regenerative Therapy Companies Taking Hold (12/07/2017)

A regenerative therapy company with expertise in both cell therapy development and manufacturing, and a potential treatment for diabetes, differentiates this company, says Hunter Diamond, CFA, CEO of Diamond Equity Research.

more>

'Prospective Explorer' Working Toward Maiden Resource (12/07/2017)

Cormark Securities provided an update on this company's gold project in central Wyoming.

more>

Biotech Delivers 'Great' Phase 2 Data in NASH (12/07/2017)

John McCamant of the Medical Technology Stock Letter raised his target price on this company given the earning potential of a once-a-day oral treatment for liver disease in what could be a $35 billion market.

more>

Two 100%-Owned Projects Have Analysts Talking About a Possible 'JV Partnership Offer' (12/07/2017)

With an advanced project being looked at by potential partners and a newer project producing precious metal results, several analysts rate this precious metals explorer a "Buy."

more>

A Gold Explorer's Productive November Has Analysts Saying 'Buy' (12/07/2017)

Multiple projects are showing positive and possible expansions for this gold miner.

more>

Shining a Light on an Out-of-Favor Oil Stock (12/07/2017)

Technical analyst Clive Maund charts an oil and gas explorer that he believes is under the radar of most investors.

more>

Immuno-Oncology Candidate Yields 'Impressive' Early Clinical Results (12/06/2017)

This biotech reported positive results in a Phase 1b trial for its ovarian cancer immuno-oncology drug-delivery candidate, prompting increases in share price targets from a pair of analysts.

more>

Coverage Initiated on 'One of the Most Undervalued Biotech Companies in Canada' (12/06/2017)

David Kideckel, an analyst with Beacon Securities Ltd., explained the investment thesis for this clinical-stage life sciences firm.

more>

Another Uranium Company to Slash Production in 2018 (12/05/2017)

A BMO Capital Markets report describes the implications of this cutback in production for the uranium market.

more>

Biotech Advances Potential 'Billion-Dollar Drug' with New Trial Launch in China (12/05/2017)

Maxim Group analyst Jason Kolbert discussed what the launch of a clinical trial in China means for this developer of immuno-oncology therapies.

more>

Will 2+2=8 For Columbus Gold? (12/05/2017)

Bob Moriarty of 321 Gold discusses why he believes a spinout could be a win for investors.

more>

Jack Chan's Weekly Precious Metals Report Also Charts Big Moves for Gold Major (12/04/2017)

Technical analyst Jack Chan charts the latest moves in the gold and silver markets, as well as the one-day fluctuations of a gold major.

more>

Drug in Combination with Merck's Blockbuster Keytruda Nearly Doubles Response Rate (12/04/2017)

Michael Sheikh, the founder of Falcon Strategic Research, delves into a biotech company whose trial results he believes could fuel takeover speculation.

more>

Agricultural Drone Nano-Cap Inks Deal with Monsanto Subsidiary (12/04/2017)

As farming becomes increasingly centralized, the need for precise agricultural data grows. Streetwise Reports spoke with Rick Mills, founder of Ahead of the Herd, and Fabrice Taylor, publisher of President's Club, on the fusion of drone-supplied data and data analytics.

more>

Explorer to Drill Flagship Copper Project with 'Blockbuster Discovery Hole' (12/01/2017)

Peter Epstein, founder of Epstein Research, evaluates Centenera Mining Corp.'s Esperanza copper-gold porphyry project.

more>

Silver and Gold Bottom Soon (12/01/2017)

Gold and silver are on track to hit a yearly low this December, as they have for the past five years, says Bob Moriarty of 321 Gold, who explains his reasoning and why he welcomes these moves.

more>

The True Meaning of Bitcoin's 'Success' (12/01/2017)

Precious metals expert Michael Ballanger discusses Bitcoin, currency devaluation, and gold and silver.

more>

More Archives

2017Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2013Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2012Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Newsletter Free

A valid email address is required to subscribe